v3.26.1
INVESTMENTS IN EQUITY SECURITIES (Tables)
6 Months Ended
Jun. 30, 2026
Schedule of Investments [Abstract]  
SCHEDULE OF INVESTMENTS

The following table summarizes the Company’s investments for the periods presented:

 

   June 30, 2026   December 31, 2025 
    Carrying Amount    Economic Interest    Carrying Amount    Economic Interest 
Equity Method Investments                    
Biomimetic Innovations Limited  $8,004,716    11.95%  $8,741,389    12.50%
ChemoMouthpiece, LLC   4,688,613    6.59%   4,841,695    6.59%
SI Healthcare Technologies, LLC   37,374    50.00%   43,774    50.00%
Total Equity Method Investments  $12,730,703        $13,626,858      
                     
Cost Method Investment                    
Direct Dermatology Inc.  $1,000,000        $1,000,000      
Total Cost Method Investment  $1,000,000        $1,000,000      
                     
Total Investments  $13,730,703        $14,626,858      
SCHEDULE OF LOSS FROM EQUITY METHOD INVESTMENT

The following table summarizes the Company’s share of losses from equity method investments reflected in the Company’s Consolidated Statements of Operations for the periods presented:

 

   2026   2025   2026   2025 
  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2026   2025   2026   2025 
Equity Method Investments                    
Biomimetic Innovations Limited  $(366,471)  $(122,303)  $(736,673)  $(191,879)
ChemoMouthpiece, LLC   (67,177)   (80,452)   (153,082)   (154,484)
SI Healthcare Technologies, LLC   -    7,273    (6,400)   7,273 
Total  $(433,648)  $(195,482)  $(896,155)  $(339,090)